"ADXS-NEO addendum: ADXS probably should have left the complex manufacturing of NEO to partner, AMGN, instead of trying to do it in-house." Manufacturing for NEO is not being done in-house. https://www.syntheticgenomics.com/synthetic-genomics-launches-cgmp-suite-for-pharmaceutical-quality-manufacturing-of-synthetic-dna-for-advaxis-clinical-trials/